Moreover, the proliferation of the breast cancer cell line BT-474 was not affected by direct treatment with NK20a, indicating that IL-10 might not directly be involved in the proliferation and survival pathways of breast cancer cells. This evidence concerns the gene IL10 and breast carcinoma.